BRIEF published on 10/14/2025 at 07:05, 1 year ago Innate Pharma Highlights Lacutamab at Analyst and Investor Event Investors Clinical Trial Innate Pharma Lacutamab Sézary Syndrome
BRIEF published on 10/14/2025 at 07:05, 1 year ago Innate Pharma met en avant lacutamab lors d'un événement analystes et investisseurs Investisseurs Essai Clinique Innate Pharma Lacutamab Syndrome De Sézary
PRESS RELEASE published on 10/14/2025 at 07:00, 1 year ago Inside Information / Other news releases Innate Pharma to host analyst and investor event on Lacutamab on October 28, 2025. Event includes clinical perspectives, market outlook, and updates on Phase 3 trial and regulatory pathway for lacutamab Phase 3 Trial Investor Event Regulatory Pathway Innate Pharma Lacutamab
PRESS RELEASE published on 10/14/2025 at 07:00, 1 year ago Informations privilégiées / Autres communiqués Innate Pharma organise un événement analystes et investisseurs dédié à Lacutamab le 28 octobre 2025, mettant en lumière les perspectives cliniques et commerciales du produit Investisseurs Événement Innate Pharma Analystes Lacutamab
PRESS RELEASE published on 09/22/2025 at 13:41, 1 year 1 month ago Informations privilégiées / Communiqué sur comptes, résultats
PRESS RELEASE published on 09/17/2025 at 07:00, 1 year 1 month ago Informations privilégiées / Communiqué sur comptes, résultats
BRIEF published on 09/10/2025 at 10:35, 1 year 2 months ago Innate Pharma Annonce une Conférence Téléphonique pour ses Résultats Semestriels 2025 Résultats Financiers Immunothérapie Conférence Téléphonique Partenariats Biopharmaceutiques Innate Pharma
BRIEF published on 09/10/2025 at 10:35, 1 year 2 months ago Innate Pharma Announces 2025 Half-Year Results Conference Call Financial Results Conference Call Immunotherapy Innate Pharma Biopharmaceutical Partnerships
PRESS RELEASE published on 09/10/2025 at 10:30, 1 year 2 months ago Inside Information / Other news releases Innate Pharma schedules conference call and webcast for first half 2025 financial results and business update. Details for participation available on the company's website Financial Results Conference Call Business Update Webcast Innate Pharma
PRESS RELEASE published on 09/10/2025 at 10:30, 1 year 2 months ago Informations privilégiées / Autres communiqués Innate Pharma organise une conférence téléphonique pour présenter ses résultats financiers et l’avancée de son portefeuille au premier semestre 2025 Résultats Financiers Conférence Téléphonique Portefeuille Innate Pharma Biotechnologies
Published on 11/10/2026 at 22:00, 1 minute ago Worksport Q3 Net Sales Increase 44.2% Year-Over-Year to a Record $7.2 Million Worksport (NASDAQ: WKSP) Q3 Revenue Rises 44% to Record $7.23 Million as Net Loss Narrows 28%
Published on 11/10/2026 at 21:00, 1 hour 1 minute ago Golden Minerals Announces Completion of Offering for C$5,000,000
Published on 11/10/2026 at 14:45, 7 hours 16 minutes ago An Investigational Drug to Tackle Measles Outbreaks
Published on 11/10/2026 at 14:31, 7 hours 30 minutes ago First Breach Plans to Integrate Onboard AI Computing into CQS and LRS Drone Platforms
Published on 11/10/2026 at 14:30, 7 hours 31 minutes ago Stabilis Solutions Announces Three-Year Take-Or-Pay LNG Supply Agreement with Existing Aerospace Customer
Published on 11/10/2026 at 19:21, 2 hours 40 minutes ago ALTHEORA, Mäder Composites France et IPC s'associent pour donner une seconde vie aux matériaux composites
Published on 11/10/2026 at 18:54, 3 hours 7 minutes ago REPLOID Group AG pursues entry in the US market and secures exclusivity to conduct due diligence for the potential acquisition of Chapul, LLC.
Published on 11/10/2026 at 18:45, 3 hours 16 minutes ago Special Optics Introduces Purpose-Built Microscope Objectives for Quantum Applications
Published on 11/10/2026 at 18:00, 4 hours 1 minute ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 4 hours 16 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 4 hours 26 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 4 hours 30 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.
